Cipla
Mohit Mundra is an experienced finance professional with a strong career in the pharmaceutical industry. Currently serving as the Director of Finance at Cipla, previous roles include Site Finance Head at Cipla Ltd. in Sikkim and Head of Finance at Cipla New York (InvaGen Pharmaceuticals Inc, USA). Mohit began the career as a Finance Manager with Cipla and previously held the position of Sr. Officer F&A at Bridgestone India Pvt Ltd. Educational credentials include a PGDBA in Business Administration from IMT and an Accounting Technician designation from ICAI, pursued from 2000 to the present.
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.